Harnessing nutrition to combat MASLD: a comprehensive guide to food-based therapeutic strategies
Metabolic dysfunction-associated steatotic liver disease is a growing global health issue linked to obesity, insulin resistance, and metabolic syndrome. Diet plays a key role in its progression and management. This narrative review highlights evidence-based nutritional strategies, including the Mediterranean diet, low-carbohydrate and ketogenic diets, and high-fiber intake, which improve insulin sensitivity, reduce hepatic fat, and lower inflammation. Nutritional deficiencies, such as low vitamin D, choline, and omega-3 levels, exacerbate metabolic dysfunction-associated steatotic liver disease, emphasizing the need for targeted supplementation. Emerging approaches, including gut microbiota modulation, precision nutrition, and nutraceuticals like resveratrol and curcumin, offer promising therapeutic potential. A multidisciplinary approach integrating dietary and lifestyle modifications is essential for effective metabolic dysfunction-associated steatotic liver disease management.
Authors
- Gerardo Sarno (ORCID: https://orcid.org/0000-0002-1161-0846)
- Evelyn Frías-Toral (ORCID: https://orcid.org/0000-0002-2228-0141)
- Daniel Simancas‐Racines (ORCID: https://orcid.org/0000-0002-3641-1501)
- Martín Campuzano-Donoso (ORCID: https://orcid.org/0000-0001-5317-8548)
- Náthaly Mercedes Román-Galeano (ORCID: https://orcid.org/0000-0002-6417-5550)
- Claudia Reytor-González (ORCID: https://orcid.org/0009-0007-4234-5524)
- J. García Castaño (ORCID: https://orcid.org/0009-0005-3495-1802)
Institutions
- Universidad Espíritu Santo (EC)
- Universidad UTE (EC)
- Ospedali Riuniti San Giovanni di Dio e Ruggi d'Aragona (IT)
- Indiana University School of Medicine
- Indiana University (US)
Publication Details
- Journal
- Food and Agricultural Immunology
- Published
- 2025-05-06
- DOI
- https://doi.org/10.1080/09540105.2025.2496499
- Citations
- 6
- Primary Topic
- Nutrition, Genetics, and Disease
- Type
- article
- Field-Weighted Citation Impact
- 10.90